Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 06:56:07 UTC |
---|
Update Date | 2021-09-26 23:01:08 UTC |
---|
HMDB ID | HMDB0249969 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | (2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol |
---|
Description | (2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol belongs to the class of organic compounds known as phenylpiperazines. Phenylpiperazines are compounds containing a phenylpiperazine skeleton, which consists of a piperazine bound to a phenyl group. Based on a literature review very few articles have been published on (2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol. This compound has been identified in human blood as reported by (PMID: 31557052 ). (2r)-1,1,1-trifluoro-2-{4-[(2s)-2-{[(3s)-3-methylmorpholin-4-yl]methyl}-4-(thiophen-2-ylsulfonyl)piperazin-1-yl]phenyl}propan-2-ol is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC1COCCN1CC1CN(CCN1C1=CC=C(C=C1)C(C)(O)C(F)(F)F)S(=O)(=O)C1=CC=CS1 InChI=1S/C23H30F3N3O4S2/c1-17-16-33-12-11-27(17)14-20-15-28(35(31,32)21-4-3-13-34-21)9-10-29(20)19-7-5-18(6-8-19)22(2,30)23(24,25)26/h3-8,13,17,20,30H,9-12,14-16H2,1-2H3 |
---|
Synonyms | Value | Source |
---|
(2R)-1,1,1-Trifluoro-2-{4-[(2S)-2-{[(3S)-3-methylmorpholin-4-yl]methyl}-4-(thiophen-2-ylsulphonyl)piperazin-1-yl]phenyl}propan-2-ol | Generator | 1,1,1-Trifluoro-2-(4-{2-[(3-methylmorpholin-4-yl)methyl]-4-(thiophene-2-sulphonyl)piperazin-1-yl}phenyl)propan-2-ol | HMDB |
|
---|
Chemical Formula | C23H30F3N3O4S2 |
---|
Average Molecular Weight | 533.63 |
---|
Monoisotopic Molecular Weight | 533.162983295 |
---|
IUPAC Name | 1,1,1-trifluoro-2-(4-{2-[(3-methylmorpholin-4-yl)methyl]-4-(thiophene-2-sulfonyl)piperazin-1-yl}phenyl)propan-2-ol |
---|
Traditional Name | 1,1,1-trifluoro-2-(4-{2-[(3-methylmorpholin-4-yl)methyl]-4-(thiophene-2-sulfonyl)piperazin-1-yl}phenyl)propan-2-ol |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC1COCCN1CC1CN(CCN1C1=CC=C(C=C1)C(C)(O)C(F)(F)F)S(=O)(=O)C1=CC=CS1 |
---|
InChI Identifier | InChI=1S/C23H30F3N3O4S2/c1-17-16-33-12-11-27(17)14-20-15-28(35(31,32)21-4-3-13-34-21)9-10-29(20)19-7-5-18(6-8-19)22(2,30)23(24,25)26/h3-8,13,17,20,30H,9-12,14-16H2,1-2H3 |
---|
InChI Key | OJTJLEFGCNYTBQ-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylpiperazines. Phenylpiperazines are compounds containing a phenylpiperazine skeleton, which consists of a piperazine bound to a phenyl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazinanes |
---|
Sub Class | Piperazines |
---|
Direct Parent | Phenylpiperazines |
---|
Alternative Parents | |
---|
Substituents | - Phenylpiperazine
- N-arylpiperazine
- Tertiary aliphatic/aromatic amine
- Aniline or substituted anilines
- Dialkylarylamine
- Monocyclic benzene moiety
- Morpholine
- Oxazinane
- Organosulfonic acid amide
- Benzenoid
- Organic sulfonic acid or derivatives
- Organosulfonic acid or derivatives
- Heteroaromatic compound
- Sulfonyl
- Tertiary alcohol
- Thiophene
- Tertiary aliphatic amine
- Tertiary amine
- Fluorohydrin
- Halohydrin
- Azacycle
- Oxacycle
- Dialkyl ether
- Ether
- Aromatic alcohol
- Organooxygen compound
- Organonitrogen compound
- Organofluoride
- Organohalogen compound
- Organic oxygen compound
- Organosulfur compound
- Organic oxide
- Hydrocarbon derivative
- Alcohol
- Alkyl fluoride
- Alkyl halide
- Organic nitrogen compound
- Amine
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
(2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol,1TMS,isomer #1 | CC1COCCN1CC1CN(S(=O)(=O)C2=CC=CS2)CCN1C1=CC=C(C(C)(O[Si](C)(C)C)C(F)(F)F)C=C1 | 3630.7 | Semi standard non polar | 33892256 | (2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol,1TMS,isomer #1 | CC1COCCN1CC1CN(S(=O)(=O)C2=CC=CS2)CCN1C1=CC=C(C(C)(O[Si](C)(C)C)C(F)(F)F)C=C1 | 3492.2 | Standard non polar | 33892256 | (2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol,1TMS,isomer #1 | CC1COCCN1CC1CN(S(=O)(=O)C2=CC=CS2)CCN1C1=CC=C(C(C)(O[Si](C)(C)C)C(F)(F)F)C=C1 | 4469.7 | Standard polar | 33892256 | (2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol,1TBDMS,isomer #1 | CC1COCCN1CC1CN(S(=O)(=O)C2=CC=CS2)CCN1C1=CC=C(C(C)(O[Si](C)(C)C(C)(C)C)C(F)(F)F)C=C1 | 3849.2 | Semi standard non polar | 33892256 | (2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol,1TBDMS,isomer #1 | CC1COCCN1CC1CN(S(=O)(=O)C2=CC=CS2)CCN1C1=CC=C(C(C)(O[Si](C)(C)C(C)(C)C)C(F)(F)F)C=C1 | 3743.1 | Standard non polar | 33892256 | (2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol,1TBDMS,isomer #1 | CC1COCCN1CC1CN(S(=O)(=O)C2=CC=CS2)CCN1C1=CC=C(C(C)(O[Si](C)(C)C(C)(C)C)C(F)(F)F)C=C1 | 4461.2 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol 10V, Positive-QTOF | splash10-001i-0000090000-684654d994e0781c802a | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol 20V, Positive-QTOF | splash10-001l-0000980000-cd1bd6640eebf3ff1b09 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol 40V, Positive-QTOF | splash10-0a5c-3138930000-e1754c1538e193cc1eca | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol 10V, Negative-QTOF | splash10-001i-0000190000-935088c1d7c63394fc57 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol 20V, Negative-QTOF | splash10-02ai-0003960000-ac31514c4fa2b938a532 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol 40V, Negative-QTOF | splash10-0089-5912110000-2e992685c5b063c8c6fa | 2021-10-12 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | Not Available |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 70655675 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]
|
---|